ANSTO has appointed a new chief executive to lead the organisation for the next three years.
ANSTO chair Dr Annabelle Bennett announced the appointment of Shaun Jenkinson last month following a rigorous selection process.
His appointment came after a global search to replace Dr Adi Paterson, who stepped down last year after more than a decade at the helm.
Mr Jenkinson had been acting in the role since September.
Mr Jenkinson has more than 30 years' experience across the pharmaceuticals, medical equipment and medical devices industries.
He has a degree in Biotechnology and is a graduate of the Australian Institute of Company Director
Since joining ANSTO in 2010, he has focussed on applying science to assist industry and government.
As group executive of nuclear business, his role covered all commercial operations including ANSTO Health, ANSTO Minerals, ANSTO Silicon, Mo-99 Operations, ANSTO Radiation Services, Business Development and international business partnerships.
He ensured reliable supply of radioisotopes to the domestic market, as well as delivering export sales growth.
Dr Bennett said there was no doubt he was the right person to guide ANSTO.
"This is an important time for ANSTO, to ensure continued sustainability and delivery of nuclear medicines and other products and services that make major contributions to the Australian community," she said.
Mr Jenkinson said it was a huge privilege and a great responsibility to take on the role.
"I will commit to it with everything I have to create an environment where both the individual and the combined efforts of the talented people at ANSTO are recognised and can flourish," he said.
"Translating great science into outcomes that support Australia's research priorities is critical to our prosperity, and I know that the team at ANSTO has always, and will always, rise to that challenge.
"I look forward to working with everyone as we progress towards our goals."
ANSTO is home to Australia's most significant landmark and national infrastructure for research, including the OPAL nuclear reactor in Lucas Heights, and the Australian Synchrotron in Melbourne.
